Where’s Waldo: Global Discovery and Finding a Corporation October 5, 2022PatentCertiorari, Discovery, Eli Lilly, Northern District of California, paid, Personal JurisdictionDennis Crouch To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
Doctrine of Equivalents is on Revival August 9, 2019PatentClaim Construction, Doctrine of Equivalents, Eli Lilly, paid, Patent Infringement, Pharmaceutical PatentsDennis Crouch To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
A Functionally Claimed One-Step Method June 7, 2019PatentCertiorari, Eli Lilly, Functional Claiming, Halliburton v. Walker, paidDennis Crouch To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
Proving Non-Obviousness with Ex-Post Experimental Evidence? October 21, 2014PatentEli Lilly, En Banc, Obviousness, paid, Pharmaceutical Patents, Secondary ConsiderationsDennis Crouch To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
Ready to Nationalize Trade Secret Law? August 27, 2014PatentDirector Kappos, Eli Lilly, Legislation & Congress, paid, Trade SecretsDennis Crouch To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
Guest Post: Defend Trade Secrets Act — A Primer, an Endorsement, and a Criticism May 30, 2014Patent, Trade SecretEli Lilly, Guest Post, Legislation & Congress, Microsoft, paid, Senator Coons, Trade SecretsDennis Crouch To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
The America Invents Act: One Year Later (Pt. 5) September 14, 2012PatentAIA Transition, Eli Lilly, Inequitable Conduct, Inter Partes Review, Jason Rantanen, paid, PGR & CBM, Prior User RightsJason Rantanen To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
Teva v. Astrazeneca: Invalidating a patent with secret prior art December 1, 2011PatentAIA Transition, Anticipation, Conception & Reduction to Practice, Eli Lilly, Jason Rantanen, paid, Secret Prior Art, Teva v. LillyJason Rantanen To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
UK Patent Case Lowers Bar on Utility (Industrial Application) November 2, 2011Patent, Patent Cases 2011, PharmaEli Lilly, International & Comparative, paid, UtilityDennis Crouch To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
Federal Circuit En Banc Patent Decisions March 8, 2011PatentAppellate Procedure, Eli Lilly, En Banc, Federal Circuit, Jason Rantanen, paidJason Rantanen To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
Guest Post: Centocor, the Antibody Exception, and Claiming Only What was Invented February 27, 2011PatentBiologics & Antibodies, Conception & Reduction to Practice, Eli Lilly, Guest Post, paid, Written DescriptionJason Rantanen To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
Split Court Denies Rehearing En Banc in Sun Pharmaceuticals v. Eli Lilly November 1, 2010Obviousness, Patent, Patent Cases 2010, RantanenDouble Patenting, Eli Lilly, En Banc, Jason Rantanen, paidJason Rantanen To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
Teva v. Eisai: Standing for subsequent Paragraph IV filers October 6, 2010Declaratory Judgment, Patent, Patent Cases 2010, Pharma, StandingDeclaratory Judgment, Eli Lilly, Hatch-Waxman, Jason Rantanen, paid, Standing, Teva v. SandozJason Rantanen To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
Sun Pharmaceuticals v. Eli Lilly: obviousness-type double patenting in the pharmaceutical context August 2, 2010Claim Construction, Obviousness, Patent, Patent Cases 2010, Pharma, RantanenDouble Patenting, Eli Lilly, Hatch-Waxman, Jason Rantanen, Obviousness, paid, Pharmaceutical PatentsJason Rantanen To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
Guest Essay: An Initial Comment on Ariad: Written Description and the Baseline of Patent Protection for After-Arising Technology April 12, 2010PatentEli Lilly, En Banc, paid, Written DescriptionDennis Crouch To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
An Initial Comment on Ariad: Written Description and the Baseline of Patent Protection for After-Arising Technology April 12, 2010JournalEli Lilly, En Banc, paid, Written DescriptionDennis Crouch To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
Guest Post: Ariad v. Lily: Choosing to Not Disrupt the Settled Expectations of the Patent Community March 28, 2010PatentAriad v. Eli Lilly, Biotechnology & Chemistry, Eli Lilly, En Banc, Guest Post, paid, Written DescriptionDennis Crouch To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
Federal Circuit Confirms that Patents Must Meet Both the Written Description and Enablement Requirements of Section 112. March 22, 2010PatentEli Lilly, En Banc, Enablement, paid, Written DescriptionDennis Crouch To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
Ariad v. Eli Lilly: Written Description Requirement February 19, 2010PatentEli Lilly, En Banc, paid, Written DescriptionDennis Crouch To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.
An Empirical Study of the Role of The Written Description Requirement in Patent Prosecution February 18, 2010Academic Studies, Articles and Publications, En Banc, Enablement, PatentAriad v. Eli Lilly, Eli Lilly, En Banc, paid, Patent Prosecution, Written DescriptionDennis Crouch To continue reading, become a Patently-O member. Already a member? Simply log in to access the full post.